Dobutamine Hydrochloride 50mg Injection IP

Send Inquiry

Request To Call Back

Dobutamine Hydrochloride 50mg Injection IP

Get a Price/Quote

MOQ : 100 Vials

Dobutamine Hydrochloride 50mg Injection IP Specification

Packaging Type
Glass ampoule

Life Span
24 months from manufacturing date.

Dosage Form
Parenteral injection

Salt Composition
Dobutamine Hydrochloride

Brand Name
Dobutamine Hydrochloride Injection IP

Indication
Short-term treatment of patients with cardiac decompensation due to depressed contractility resulting from organic heart disease or cardiac surgical procedures.

Pacakaging (Quantity Per Box)
5 ampoules per box

Origin of Medicine
India

Drug Type
Cardiovascular agent/Prescription drug

Ingredients
Dobutamine Hydrochloride 50mg/ml

Physical Form
Liquid (Injection)

Function
Inotropic cardiac agent - increases myocardial contractility and cardiac output.

Recommended For
Cardiac stimulant in the treatment of acute heart failure, cardiogenic shock, and to support cardiac output during cardiac surgery.

Dosage
As prescribed by physician, typically started at 2.5 to 10 mcg/kg/min IV infusion, adjusted as needed.

Dosage Guidelines
Administer by intravenous infusion only. Must be diluted before use and given only in hospital settings with monitoring.

Suitable For
Adults and elderly patients (Use in children only with specialist advice).

Quantity
5 x 5 ml ampoules per box

Storage Instructions
Store below 25C. Protect from light and moisture. Do not freeze.

Caution
To be diluted prior to use. For hospital use only under strict medical supervision.

Export Markets
Available for export to Africa, Latin America, Southeast Asia, and CIS countries.

Preservation
Contains no antimicrobial preservative. Discard unused portion.

Contraindications
Pheochromocytoma, idiopathic hypertrophic subaortic stenosis, hypersensitivity to dobutamine.

Manufactured By
Indian pharmaceutical manufacturer, GMP certified facility.

Available Strengths
50mg/5ml. Other strengths may be available upon request.

Appearance
Clear, colorless to pale yellow solution

Regulatory Status
Approved formulation - Schedule H prescription medication in India.

Strength
50 mg/5 ml (10 mg/ml)

Route of Administration
Intravenous infusion only

Dobutamine Hydrochloride 50mg Injection IP Trade Information

Minimum Order Quantity
100 Vials

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

About Dobutamine Hydrochloride 50mg Injection IP

Monark Biocare is the trusted ISO certified Pharma Company in Bhavnagar. With a decade of experience, we have cemented our position as trusted manufacturers and suppliers of top-notch pharmaceutical products across India. We are WHO-GMP, GLP certified company in India with the exclusive range of pharma products. Our extensive product portfolio includes a diverse range of tablets, capsules, injectables, syrups, ointments, nasal drops, etc.

Effective Cardiac Support for Acute Conditions

Dobutamine Hydrochloride Injection IP is specifically recommended for short-term management of cardiac decompensation resulting from depressed myocardial contractility due to heart disease or surgical procedures. As an inotropic agent, it is invaluable for hospitals managing critically ill patients requiring rapid improvement in cardiac output and perfusion.

Strictly for Hospital Use Under Expert Supervision

Administration is restricted to hospital settings with capabilities for close monitoring of cardiac function. Infusion must be tailored to individual needs, starting at standard dosages and titrated by a physician according to response. Unused portions are to be discarded as the formulation contains no antimicrobial preservative.

Quality and Compliance You Can Trust

This injection is produced in a GMP-certified Indian facility, ensuring stringent quality and regulatory compliance. It is supplied in glass ampoules for optimal stability and safety, with each box containing five 5-ml ampoules. Product is available for export to Africa, Latin America, Southeast Asia, and CIS countries.

FAQ's of Dobutamine Hydrochloride 50mg Injection IP:

Q: How should Dobutamine Hydrochloride 50mg Injection IP be administered?

A: This medication is only administered by intravenous infusion in hospital settings. It must be diluted before use and given under the direct supervision of healthcare professionals who can monitor cardiac function throughout the treatment.

Q: What is the benefit of using Dobutamine Hydrochloride Injection in cardiac patients?

A: Dobutamine Hydrochloride Injection acts as an inotropic cardiac agent, meaning it enhances the heart's pumping strength (contractility), leading to increased cardiac output. This is crucial in cases of acute heart failure, cardiogenic shock, or temporarily supporting the heart during and after cardiac surgery.

Q: When is Dobutamine Hydrochloride Injection IP indicated?

A: It is indicated for the short-term treatment of patients experiencing cardiac decompensation due to reduced heart muscle contractility, stemming from organic heart disease or complications following cardiac surgery.

Q: Where is Dobutamine Hydrochloride Injection manufactured and available?

A: The product is manufactured in a GMP-certified facility in India. It is approved and available for hospital use within India and is also exported to Africa, Latin America, Southeast Asia, and CIS countries.

Q: What is the process for storing and handling Dobutamine Hydrochloride Injection?

A: Ampoules must be stored below 25C, away from light and moisture, and should not be frozen. Since it contains no antimicrobial preservatives, any unused portion should be discarded immediately after opening.

Q: Who is suitable for treatment with Dobutamine Hydrochloride Injection?

A: This injection is intended for adults and elderly patients. Use in children should only occur under the guidance of a pediatric specialist. It should not be used in patients with pheochromocytoma, idiopathic hypertrophic subaortic stenosis, or those with hypersensitivity to dobutamine.

Tell us about your requirement